Cipher Pharmaceuticals Inc. (CPHRF)

Cipher Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	20.38	26.64	7.76	4.55	3.24
Depreciation & Amortization	1.25	0.99	0.7	1.21	1.19
Share-Based Compensation	1.19	0.4	0.14	0.12	0
Other Operating Activities	-6.53	-17.45	5.22	5.82	4.43
Operating Cash Flow	16.29	10.58	13.81	11.69	8.86
Operating Cash Flow Growth	54.07%	-23.45%	18.16%	31.95%	-21.48%
Capital Expenditures	-0.15	-0.08	0	-0.76	-1.31
Acquisitions	0	0	0	0	-0.37
Other Investing Activities	-	-	-	-	0.22
Investing Cash Flow	-0.15	-0.08	0	-0.76	-1.46
Common Stock Issued	0.43	0.13	0.07	0.04	0.07
Share Repurchases	-5.66	-1.99	-1.72	-0.08	0
Other Financing Activities	-11.43	-4.03	-4.26	-8.25	-10.6
Financing Cash Flow	-5.34	-1.91	-2.47	-8.13	-10.53
Net Cash Flow	10.8	8.29	11.41	2.8	-4.01
Free Cash Flow	16.15	10.49	13.81	10.93	7.55
Free Cash Flow Growth	53.86%	-24.03%	26.37%	44.80%	62.13%
Free Cash Flow Margin	74.92%	50.76%	62.95%	50.59%	33.62%
Free Cash Flow Per Share	0.64	0.41	0.51	0.40	0.28

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.